Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: cerebrovascular accident,cost of (Click to remove) Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999 Inpatient Costs, Length of Stay, and Mortality for Cerebrovascular Events in Community Hospitals Neurol 57:305-314, Reed,S.D.,et al, 2001 Direct Costs of Transient Ischemic Attacks,A Hospital-Based Study of Resource Use During the First Year After Transient Ischemic Attacks in Denmark Stroke 29:2321-2324, Porsdal,V.&Boysen,G., 1998 Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs Arch Int Med 158:1641-1647, Chiquette,E.,et al, 1998 Cost-Effectiveness of Intravenous Thrombolysis With Alteplase Within a 3-Hour Window After Acute Ischemic Stroke Stroke 38:85-89, Ehlers,L.,et al, 2007 Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007 Long-Term Outcome After Thrombolysis in Telemedical Stroke Care Neurol 69:898-903,819, Schwab,S.,et al, 2007 Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005 Diagnosis and Treatment of Ischemic Stroke Am J Med 106:211-221, Alberts,M.J., 1999 Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke Stroke 30:2094-2100, Suarez,J.I.,et al, 1999 Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach Stroke 29:1544-1549, Grond,M.,et al, 1998 Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke Neurol 50:883-890, Fagan,S.C.,et al, 1998 Showing articles 0 to 12 of 12